Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
125.00
+1.09 (+0.88%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,306,329
Open
124.21
Bid (Size)
125.00 (400)
Ask (Size)
125.28 (500)
Prev. Close
123.91
Today's Range
123.88 - 125.60
52wk Range
88.57 - 128.70
Shares Outstanding
1,253,809,440
Dividend Yield
2.53%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away
↗
Today 9:34 EST
This investor just walked away as Scholar Rock heads into a pivotal 2026—here’s what that means for long-term shareholders.
Via
The Motley Fool
Topics
Regulatory Compliance
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing
↗
December 01, 2025
Via
MarketBeat
Performance
YTD
+36.0%
+36.0%
1 Month
+2.4%
+2.4%
3 Month
+10.6%
+10.6%
6 Month
+14.7%
+14.7%
1 Year
+35.1%
+35.1%
More News
Read More
Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
↗
November 28, 2025
Via
Benzinga
Top S&P500 movers in Friday's session
↗
November 28, 2025
Via
Chartmill
Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study
↗
November 19, 2025
Via
Stocktwits
These S&P500 stocks are moving in today's session
↗
November 28, 2025
Via
Chartmill
Gapping S&P500 stocks in Friday's session
↗
November 28, 2025
Via
Chartmill
Kymera (KYMR) Q3 2025 Earnings Call Transcript
↗
November 27, 2025
Via
The Motley Fool
Topics
Earnings
Gilead Sciences Inc (NASDAQ:GILD) Demonstrates Strong Dividend Reliability and Profitability
↗
November 25, 2025
Via
Chartmill
Gilead Foundation Commits Over $3 Million to Address Food Insecurity
November 24, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
$1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth This Much Today
↗
November 20, 2025
Via
Benzinga
Gilead Sciences Inc Chart Analysis
↗
November 19, 2025
Via
Talk Markets
Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment
↗
November 19, 2025
Via
Benzinga
Wall Street Braces for Impact as Delayed Jobs Report Emerges from Data Blackout
November 19, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Uncover the latest developments among S&P500 stocks in today's session.
↗
November 18, 2025
Via
Chartmill
Gilead Joins Partners for Delivery of First Shipments of Breakthrough Twice-yearly Lenacapavir for HIV Prevention to Sub-Saharan Africa
November 18, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences's Options: A Look at What the Big Money is Thinking
↗
November 17, 2025
Via
Benzinga
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
1 Healthcare Stock to Own for Decades and 2 We Avoid
November 13, 2025
Via
StockStory
Topics
Stocks
Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?
November 13, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV
↗
November 13, 2025
Via
Stocktwits
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
↗
November 13, 2025
Via
Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
↗
November 13, 2025
Via
Chartmill
2 Supercharged Dividend Stocks to Buy Now
↗
November 13, 2025
Via
The Motley Fool
Topics
ETFs
Intellectual Property
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
November 13, 2025
Via
Benzinga
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 125.00
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 12/03/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 156.73B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 157B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.